Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-06

Clinical Trial Update: A Study of Intramuscular Sebacoyl Dinalbuphine Ester for Post-Hemorrhoidectomy Pain Management [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial results for intramuscular sebacoyl dinalbuphine ester in managing postoperative pain after hemorrhoidectomy have been completed and results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sebacoyl Dinalbuphine Ester (sebacoyl dinalbuphine ester)

Snippet

Sponsor: Lumosa Therapeutics Co., Ltd. | Conditions: Analgesia Disorder, Pain | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2026-01-06